Cargando…

Antibody-Drug Conjugate Targeting c-Kit for the Treatment of Small Cell Lung Cancer

Lung cancer is the leading cause of cancer-related deaths. Small cell lung cancer (SCLC) accounts for 15–25% of all lung cancers. It exhibits a rapid doubling time and a high degree of invasiveness. Additionally, overexpression of c-Kit occurs in 70% of SCLC patients. In this study, we evaluated an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kwang-Hyeok, Kim, Jin-Ock, Park, Jeong-Yang, Seo, Min-Duk, Park, Sang Gyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875948/ https://www.ncbi.nlm.nih.gov/pubmed/35216379 http://dx.doi.org/10.3390/ijms23042264

Ejemplares similares

A novel anti‐c‐Kit antibody–drug conjugate to treat wild‐type and activating‐mutant c‐Kit‐positive tumors
por: Kim, Jin‐Ock, et al.
Publicado: (2021)

A fully human anti-c-Kit monoclonal antibody 2G4 inhibits proliferation and degranulation of human mast cells
por: Kim, Kwang-Hyeok, et al.
Publicado: (2022)

A Novel Antibody-Drug Conjugate Targeting Nectin-2 Suppresses Ovarian Cancer Progression in Mouse Xenograft Models
por: Sim, Yun Hee, et al.
Publicado: (2022)

A Fully Human Monoclonal Antibody Targeting cKIT Is a Potent Inhibitor of Pathological Choroidal Neovascularization in Mice
por: Seo, Songyi, et al.
Publicado: (2021)

Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumor
por: Zhang, Dengyang, et al.
Publicado: (2022)

A CD276-Targeted Antibody-Drug Conjugate to Treat Non-Small Lung Cancer (NSCLC)
por: Zhang, Jiashuai, et al.
Publicado: (2023)

NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer
por: Yotsumoto, Takuma, et al.
Publicado: (2020)

‘Targeting’ Improved Outcomes with Antibody-Drug Conjugates in Non-Small Cell Lung Cancer—An Updated Review
por: Verma, Saurav, et al.
Publicado: (2023)

Quantitative pharmacology in antibody-drug conjugate development: armed antibodies or targeted small molecules?
por: Nessler, Ian, et al.
Publicado: (2018)

Therapeutic Efficacy of C-Kit-Targeted Radioimmunotherapy Using 90Y-Labeled Anti-C-Kit Antibodies in a Mouse Model of Small Cell Lung Cancer
por: Yoshida, Chisato, et al.
Publicado: (2013)

N-terminal selective conjugation method widens the therapeutic window of antibody–drug conjugates by improving tolerability and stability
por: Ko, Min Ji, et al.
Publicado: (2021)

Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics
por: Kim, Eunhee G., et al.
Publicado: (2015)

Antibody-drug conjugates targeting Trop-2: Clinical developments in early breast cancer therapy
por: Jeong, Jae Ho, et al.
Publicado: (2022)

Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment–Drug Conjugates
por: Kim, Eunhee G., et al.
Publicado: (2020)

Conjugates of Small Molecule Drugs with Antibodies and Other Proteins
por: Feng, Yang, et al.
Publicado: (2014)

Evaluation of two commercial PRRSV antibody ELISA kits with samples of known status and singleton reactors
por: SEO, Byoung-Joo, et al.
Publicado: (2015)

Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates
por: Belluomini, Lorenzo, et al.
Publicado: (2023)

Successful coronary stent retrieval from the ascending aorta using a gooseneck snare kit
por: Jang, Ji-Hun, et al.
Publicado: (2013)

Trends in the Development of Antibody-Drug Conjugates for Cancer Therapy
por: Song, Chi Hun, et al.
Publicado: (2023)

Targeting cancer with antibody-drug conjugates: Promises and challenges
por: Dean, Alexis Q., et al.
Publicado: (2021)

Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
por: Dugal-Tessier, Julien, et al.
Publicado: (2021)

Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer
por: Feng, Liang, et al.
Publicado: (2016)

An antibody‐drug conjugate targeting a GSTA glycosite‐signature epitope of MUC1 expressed by non‐small cell lung cancer
por: Pan, Deng, et al.
Publicado: (2020)

Antibody–Drug Conjugate to Treat Meningiomas
por: Chen, Kai, et al.
Publicado: (2021)

Impact of the conjugation of antibodies to the surfaces of polymer nanoparticles on the immune cell targeting abilities
por: Lee, Na Kyeong, et al.
Publicado: (2021)

A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
por: Jin, Yangbing, et al.
Publicado: (2021)

The Potential of Topoisomerase Inhibitor-Based Antibody–Drug Conjugates
por: Han, Seungmin, et al.
Publicado: (2022)

Computational selection of antibody-drug conjugate targets for breast cancer
por: Fauteux, François, et al.
Publicado: (2015)

Antibody drug conjugate: the “biological missile” for targeted cancer therapy
por: Fu, Zhiwen, et al.
Publicado: (2022)

Antibody-drug conjugates: the paradigm shifts in the targeted cancer therapy
por: Aggarwal, Devesh, et al.
Publicado: (2023)

Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics
por: Kumari, Mamta, et al.
Publicado: (2023)

Advances in Targeted Therapy of Breast Cancer with Antibody-Drug Conjugate
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Erratum to: Biological evaluation of antibody-maytansinoid conjugates as a strategy of RON targeted drug delivery for treatment of non-small cell lung cancer
por: Feng, Liang, et al.
Publicado: (2016)

ABBV-011, A Novel, Calicheamicin-Based Antibody–Drug Conjugate, Targets SEZ6 to Eradicate Small Cell Lung Cancer Tumors
por: Wiedemeyer, Wolf R., et al.
Publicado: (2022)

cIRCR201-dPBD, a Novel Pyrrolobenzodiazepine Dimer-Containing Site-Specific Antibody–Drug Conjugate Targeting c-Met Overexpression Tumors
por: Min, Byeongkwi, et al.
Publicado: (2020)

Unilateral administration of a drug into the lung of a small animal
por: Cheong, Soon Ho, et al.
Publicado: (2010)

Introduction to Antibody-Drug Conjugates
por: Pettinato, Mark C.
Publicado: (2021)

ANTIBODY DRUG CONJUGATES (ADCS)
por: Terpos, E.
Publicado: (2023)

Quantification of an Antibody-Conjugated Drug in Fat Plasma by an Affinity Capture LC-MS/MS Method for a Novel Prenyl Transferase-Mediated Site-Specific Antibody–Drug Conjugate
por: Lee, Byeong ill, et al.
Publicado: (2020)

A novel antibody–drug conjugate targeting SAIL for the treatment of hematologic malignancies
por: Kim, S Y, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1n423otr2ekd4ldldaeg7lt5sl